Dr Nicholas Adomakoh is the Global medical Affairs lead for Anti-infectives at Sandoz International GmbH based in Germany. He is responsible for the development and implementation of strategy to leverage the company’s antibiotic portfolio to address unmet needs in the clinical management of infectious diseases, and in tackling the challenges presented by AMR. Previously he has held Global and European region medical affairs roles in infectious diseases at Astellas Pharma Inc and BMS.
Nicholas obtained his medical degree from King’s College London in 1992, and has worked for 20 years as an infectious diseases physician prior to joining industry. During this time, he spent 10 years in strategic planning and implementation of dengue and vector-borne disease control programmes, and lead public health interventions at national and regional level, as part of the Pan Caribbean Partnership Against HIV/AIDS.
Nicholas has experience in late phase clinical trials, operations research and real world evidence studies, and has a particular interest in digital technologies as a tool for optimising the use and repurposing of antibiotics. His public health experience has made him an advocate for the role of ICT in health systems strengthening and overcoming barriers to universal health coverage in resource constrained settings.